McMillan Shakespeare Ltd

MMS: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.RVLOCK|<sLOCK|s!yRh^&

McMillan Shakespeare Earnings: Growth Is Real but Unlikely to Last at This Pace

McMillan's underlying NPATA increased 14% on last year. Group EBITDA margin grew by close to 200 basis points to 30%. Shares were up around 7% intraday.

Sponsor Center